Skip to content
Search

Latest Stories

£2.3B investment in CDC programme marks NHS's biggest MRI, CT capacity boost

£2.3B investment in CDC programme marks NHS's biggest MRI, CT capacity boost
NHS via Community Diagnostic Centre to offer MRI, CT scans, x-ray, audiology, endoscopy, respiratory, phlebotomy services 

In a groundbreaking move, Health and Social Care Secretary Victoria Atkins announced today that patients across England are now benefiting from essential diagnostic tests, checks, and scans at 160 sites under the Community Diagnostic Centre (CDC) programme by March 2025.

This initiative, situated in various locations including shopping centers, university campuses, and NHS hospitals, aims to tackle diseases like cancer and heart ailments.


With a staggering £2.3 billion investment, the CDC programme signifies the NHS's largest-ever boost in MRI and CT scanning capacity.

This monumental effort not only aims to provide additional diagnostic tests but also to relieve pressure on hospitals, ensuring swift diagnoses for patients.

As per DHSC, so far 7 million patients tests, checks, and scans have been delivered through CDC funding across England which encompasses a wide array of diagnostic services such as MRI and CT scanning equipment, x-ray, audiology, endoscopy, respiratory tests, and phlebotomy services, aiding in the diagnosis and monitoring of various conditions.

Highlighting the importance of "early diagnosis and treatment", Victoria Atkins stressed the program's role in "improving health outcomes for millions of NHS patients across England."

Minister Andrew Stephenson echoed this sentiment, emphasizing the program's crucial contribution to patient well-being.

Professor Sir Mike Richards lauded the establishment of community diagnostic centers, noting their substantial impact on meeting the rising demand for diagnostic tests.

He said, "The NHS has made great progress in establishing community diagnostic centres, which were a key recommendation in my 2020 report."

"Demand for diagnostic tests continues to rise and these new facilities – which amount to the biggest central cash investment in MRI and CT capacity in the history of the NHS - are providing much needed additional capacity," he added further.

Last month, Chancellor Jeremy Hunt unveiled further investment, promising 100 AI-fitted MRI scanners to fast-track diagnostic processes for over 130,000 patients every year

This move is part of a £4.2 billion Public Sector Productivity Plan, aiming to double the NHS's investment in digital transformation.

Patients can access CDCs through referrals from their GP or acute consultant, where state-of-the-art diagnostic equipment is utilized by healthcare staff to diagnose a range of health conditions.

The CDC programme's expansion continues, with 105 CDCs fully operational on permanent sites and an additional 55 sites providing services in temporary facilities to meet the growing demand for diagnostic services and ensuring timely healthcare delivery across England.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less